Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3

https://doi.org/10.1016/j.biocel.2013.12.016Get rights and content

Abstract

Hyaluronan (HA), a natural extracellular matrix component, has been considered as an important constituent of the stem cell niche, and successfully used as 3D scaffolds for the chondrogenic differentiation of stem cells. However, the expression levels of HA synthases (HAS1, 2 and 3) and the synthesis of HA by stem cells have remained unknown, and were studied here in the human bone marrow-derived mesenchymal stem cells (hMSCs). Nine hMSCs from different donors were cultured as monolayers with MSC culture medium supplemented with FGF-2. The amount of HA secreted into medium was studied by an ELISA-type assay, and HA bound to cell surface by live cell microscopy. The expression of HASs was analyzed by real time RT-PCR and immunostainings. The HA receptor CD44 was studied by immunocytochemistry. An intense HA coat surrounded the plasma membrane and its protrusions in all nine hMSCs. Displacement assay with HA oligosaccharides indicated that HA coat was at least partly dependent on CD44, which showed similar, relatively high expression in all hMSCs. All HAS isoenzymes were detected, HAS1 showing the largest and HAS3 the smallest range of expression levels between the hMSCs. The secretion of HA ranged between 22.5 and 397.4 ng/10,000 cells/24 h, and could not be clearly assigned to the mRNA level of a certain HAS, or a combination of the isoenzymes. This suggests that post-transcriptional and post-translational factors were involved in the adjustment of the HA secretion. In conclusion, all hMSCs expressed high levels of HAS1–3, secrete large amounts of HA, and surround themselves with a thick HA coat bound to CD44. The results suggest that hMSC has the potential for autocrine maintenance of the HA niche, important for their stemness.

Introduction

Mesenchymal stem cells (MSCs), isolated from bone marrow, have been extensively investigated (Friedenstein et al., 1970, Caplan, 1991, Prockop, 1997), and demonstrate a good potential for the cartilage repair and regeneration (Barry, 2003, Quintavalla et al., 2002, Radice et al., 2000, Yang et al., 2012). They can be expanded in reasonable quantities without a loss in their ability to differentiate (Barry, 2003, Kaitainen et al., 2013, Pittenger et al., 1999, Quintavalla et al., 2002). In three-dimensional cultures or gel-like matrix supports they mature in the presence of defined chondrogenic medium into chondrocytes, which produce type II collagen and cartilage proteoglycan (Nöth et al., 2002, Pittenger et al., 1999, Puetzer et al., 2010, Quintavalla et al., 2002, Radice et al., 2000).

Hyaluronan (HA), a nonsulfated highly hydrated glycosaminoglycan, is a natural extracellular matrix (ECM) component of the cartilage tissue. It allows cell adhesion and regulates cell proliferation, mobility and angiogenesis via activation of its receptors, CD44 (Ishida et al., 1997, Sironen et al., 2011, Slevin et al., 2002) and RHAMM (Gao et al., 2008, Turley et al., 1991). Hyaluronan is synthesized at the inner face of the cell plasma membrane by the integral membrane proteins called hyaluronan synthases (HASs), which use UDP-N-acetyl glucosamine and UDP-glucuronic acid to alternately add N-acetyl glucosamine and glucuronic acid to form HA (Prehm, 1984, Itano et al., 1999, Qu et al., 2007). The newly formed HA molecules are simultaneously translocated into extracellular space and often remain attached to cell surface, forming a relatively thick coat (Rilla et al., 2008). Three isoforms of HAS (HAS 1, 2 and 3) have been identified in various cell types (Adamia et al., 2005, Calabro et al., 2002, Itano et al., 1999, Recklies et al., 2001, Tammi et al., 2011). Hyaluronan and HASs have been indicated to have a major impact on normal, diseased and malignant cell behavior (Adamia et al., 2005, Golshani et al., 2008, Hiscock et al., 2000, Nykopp et al., 2009, Wang et al., 2006), and also stem cells (Calabro et al., 2002, Ducale et al., 2005, Zhu et al., 2006).

Hyaluronan has been considered as a potential niche matrix for stem cells due its function as a regulator of cellular behavior during embryogenesis, morphogenesis, migration, proliferation, differentiation and drug resistance (Chen et al., 2007, Jha et al., 2011, Liu et al., 2008, Liu et al., 2009, Solis et al., 2012). It has been shown in human chondrosarcoma-derived chondrocyte-like cell line (HCS2/8) that CD44 regulates cell proliferation and matrix synthesis in cartilage microenvironment by a variety of stimulatory signals through its adhesion to HA (Ishida et al., 1997). The chondrocyte pericellular matrix in the cartilage is directly assembled and retained at the cell surface through HA and its receptors (Knudson, 1993). Thus, HA-based hydrogel potentially provides a niche for MSCs in cartilage tissue engineering based on its abundance, natural pre-chondrogenic properties and easy tenability (Chung and Burdick, 2009, Erickson et al., 2009, Loken et al., 2008, Matsiko et al., 2012). On the other hand, accumulation of HA has been shown in injured cartilage (Lammi et al., 2001), and can potentially attract exogenous MSCs to the wounded area, similarly to CD44-mediated localization of MSCs into injured kidney (Herrera et al., 2007). Hyaluronan attached to the surface of connective tissue progenitor has been used for the selection of these cells from bone marrow aspirates for subsequent osteogenic induction (Caralla et al., 2012, Caralla et al., 2013).

As discussed above, there are several indications for the importance of HA in the mesenchymal stem cell niche, reported in numerous papers during recent years (Kim et al., 2012, Liu et al., 2008, Liu et al., 2009, Pilarski et al., 1999, Solis et al., 2012). However, as far as we know there are no publications that have measured HA production by the actual mesenchymal stem cells. The present study shows that human bone marrow mesenchymal stem cells express high levels of all three HAS enzymes, synthesize large amounts of hyaluronan, and surround themselves with an extensive HA coat attached to their CD44 receptor. The data suggest that the HA-rich stem cell niche is at least partly an autocrine function of the bone marrow stem cells.

Section snippets

Materials

Alpha-Modified Eagle's Medium (α-MEM), l-glutamine, fungizone and penicillin/streptomycin were obtained from Euroclone (Pero, Italy) and fetal bovine serum (FBS) from Hyclone (Thermo Scientific, Cramlington, UK). Fibroblast growth factor-2 (FGF-2) and transforming growth factor-β3 (TGF-β3) were from Peprotech (London, UK). Toluidine blue was purchased from Serva (Heidelberg, Germany). The antibody against Stro-1 was from R&D Systems (Minneapolis, MN, USA), monoclonal antibodies against CD44

Characterization of hMSCs

Although there is no single marker specific for hMSC available, there are a number of well-known markers, which are abundantly expressed in hMSCs, such as STRO-1, CD44, CD73, CD90, and CD105 (Dominici et al., 2006). In addition, hMSCs lack the expression on CD14 (expressed on monocytes and macrophages), CD19 (expressed on B cells), CD34 (expressed on primitive hematopoietic progenitors and endothelial cells) or CD45 (expressed on leukocytes) (Dominici et al., 2006). When the hMSC markers were

Discussion

Mesenchymal stem cells have been widely used in the cartilage repair and tissue engineering because of their multipotent capacity to differentiate into chondrocytes, and also into osteoblasts and adipocytes (Kaitainen et al., 2013, Prockop, 1997, Quintavalla et al., 2002) The present results indicated that the hMSCs isolated for this study were multipotential in their ability to differentiate into chondrocytes, osteoblasts and adipocytes. The hMSCs were plastic-adherent when maintained in

Conclusions

The results from the present study indicate that human bone marrow-derived MSCs express relatively high levels of all HAS isoforms producing large quantities of HA, parts of which are retained on cell surface by CD44 to create an extensive HA coat. In a favorable environment, the capacity of hMSCs to produce and retain large quantities of HA may suffice to provide the niche needed to maintain the stemness of these cells. Monitoring the expression of HASs, the synthesis and size of the HA coat

Acknowledgments

We gratefully thank Elina Reinikainen and Riikka Kärnä for their excellent assistance in the laboratory. This research was supported by strategic funding of the University of Eastern Finland (MJL), Cancer Center of Eastern Finland (RT, MT), Sigrid Juselius Foundation (RT, MT) and Kuopio University Hospital(MT).

The monoclonal antibodies H4C4, developed by J. Thomas August and James E. K. Hildeth, and Hermes 1, developed by Eugene C. Butcher, were obtained from the Developmental Studies Hybridoma

References (73)

  • N. Itano et al.

    Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

    J Biol Chem

    (1999)
  • A.K. Jha et al.

    Controlling the adhesion and differentiation of mesenchymal stem cells using hyaluronic acid-based, doubly crosslinked networks

    Biomaterials

    (2011)
  • T.A. Jokela et al.

    Cellular content of UDP-N-acetylhexosamines controls hyaluronan synthase 2 expression and correlates with O-linked N-acetylglucosamine modification of transcription factors YY1 and SP1

    J Biol Chem

    (2011)
  • W. Knudson et al.

    CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis

    Exp Cell Res

    (1996)
  • A. Matsiko et al.

    Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering

    J Mech Behav Biomed Mater

    (2012)
  • S.K. Nilsson et al.

    Hyaluronan is synthesized by primitive hemopoietic cells, participates in their lodgment at the endosteum following transplantation, and is involved in the regulation of their proliferation and differentiation in vitro

    Blood

    (2003)
  • M.S. Pandey et al.

    The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40–400 kDa, but not smaller or larger, hyaluronans

    J Biol Chem

    (2013)
  • L.M. Pilarski et al.

    Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells

    Blood

    (1999)
  • C. Qu et al.

    Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture

    Int J Biochem Cell Biol

    (2013)
  • C.J. Qu et al.

    Effects of glucosamine sulfate on intracellular UDP-hexosamine and UDP-glucuronic acid levels in bovine primary chondrocytes

    Osteoarthritis Cartilage

    (2007)
  • J. Quintavalla et al.

    Fluorescently labeled mesenchymal stem cells (MSCs) maintain multilineage potential and can be detected following implantation into articular cartilage defects

    Biomaterials

    (2002)
  • K. Rilla et al.

    Hyaluronan synthase 1 (HAS1) requires higher cellular UDP-GlcNAc concentration than HAS2 and HAS3

    J Biol Chem

    (2013)
  • K. Rilla et al.

    The hyaluronan synthesis inhibitor 4-methylumbelliferone prevents keratinocyte activation and epidermal hyperproliferation induced by epidermal growth factor

    J Invest Dermatol

    (2004)
  • R.K. Sironen et al.

    Hyaluronan in human malignancies

    Exp Cell Res

    (2011)
  • M. Slevin et al.

    Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses

    J Biol Chem

    (2002)
  • R. Tammi et al.

    Hyaluronan accumulation in human epidermis treated with retinoic acid in skin organ culture

    J Invest Dermatol

    (1989)
  • C.T. Wang et al.

    High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis

    Osteoarthritis Cartilage

    (2006)
  • S. Adamia et al.

    Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer

    Curr Drug Targets Cardiovasc Haematol Disord

    (2005)
  • F.P. Barry

    Mesenchymal stem cell therapy in joint disease

    Novartis Found Symp

    (2003)
  • A.I. Caplan

    Mesenchymal stem cells

    J Orthop Res

    (1991)
  • T. Caralla et al.

    Hyaluronan as a novel marker for rapid selection of connective tissue progenitors

    Ann Biomed Eng

    (2012)
  • T. Caralla et al.

    In vivo transplantation of autogenous marrow-derived cells following rapid intraoperative magnetic separation based on hyaluronan to augment bone regeneration

    Tissue Eng A

    (2013)
  • L.G. Chase et al.

    A novel serum-free medium for the expansion of human mesenchymal stem cells

    Stem Cell Res Ther

    (2010)
  • M. Choudhary et al.

    Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization

    Stem Cells

    (2007)
  • C. Chung et al.

    Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis

    Tissue Eng A

    (2009)
  • D.E. Discher et al.

    Growth factors, matrices, and forces combine and control stem cells

    Science

    (2009)
  • Cited by (58)

    • Extracellular matrix-based cancer targeting

      2021, Trends in Molecular Medicine
    • Mesenchymal stem cell–derived extracellular vesicles improve the molecular phenotype of isolated rat lungs during ischemia/reperfusion injury

      2019, Journal of Heart and Lung Transplantation
      Citation Excerpt :

      Specifically, HA elicits divergent responses depending on its molecular weight: low-molecular-weight (LMW) HA is proinflammatory and acts as an endogenous danger signal,53,54 whereas high-molecular-weight HA promotes immunotolerance and tissue regeneration.55,56 Human MSCs constitutively synthesize large amounts of HA, which appear to be involved in both MSC-induced immunomodulation57,58 and tissue remodeling/regeneration.59,60 In addition, HA participates in EV shedding,61 and EVs collected from synovial fluid were recently found to be coated with HA.62

    View all citing articles on Scopus
    View full text